What is the name of your organization?
Ultraqoz LLC
What is the name of your solution?
Ultraqoz Device
Provide a one-line summary or tagline for your solution.
Ultraqoz: A portable, affordable device using liquid biopsy and telehealth to provide real-time cancer monitoring in underserved communities.
In what city, town, or region is your solution team headquartered?
Austin, TX, USA
In what country is your solution team headquartered?
United States
What type of organization is your solution team?
For-profit, including B-Corp or similar models
Film your elevator pitch.
—
What specific problem are you solving?
Ultraqoz is addressing the lack of accessible, timely cancer monitoring and diagnosis in Uganda, where cancer patients especially those undergoing chemotherapy face long delays, limited follow-up and high mortality due to inadequate diagnostic infrastructure. Uganda records over 32,000 new cancer cases annually, yet more than 80% are diagnosed at late stages, and over 60% die within one year of diagnosis (WHO, 2023). The Uganda Cancer Institute, the regional main oncology center is overwhelmed, serving millions with limited imaging and lab resources. Patients from rural areas must travel hundreds of kilometers to access care, often missing critical follow-up visits due to cost and distance. Chemotherapy is frequently administered without real-time monitoring, increasing the risk of ineffective treatment and complications. This challenge reflects a broader global issue: over 70% of cancer deaths occur in low- and middle-income countries due to diagnostic delays and infrastructure gaps (Lancet Oncology, 2022). Contributing factors include centralized healthcare systems, high costs of imaging equipment, shortage of specialists, and lack of non-invasive monitoring options. Ultraqoz addresses these by providing a low-cost, portable device that uses liquid biopsy and telehealth to enable real-time cancer monitoring at the point of care.
What is your solution?
Ultraqoz is a portable, noninvasive cancer diagnostic device that enables real time monitoring of cancer progression and treatment response using a small blood sample. Unlike traditional methods that rely on expensive imaging or invasive tissue biopsies, Ultraqoz uses liquid biopsy technology to detect circulating tumor cells (CTCs) directly from the bloodstream. The device works by drawing a small blood sample, which passes through a microfiltration membrane that isolates cancer cells. These cells are then illuminated using infrared fluoroscopy, a safe light based imaging technique, making them easy to visualize and count. This provides doctors with immediate insight into how well a patient is responding to chemotherapy or whether the disease is progressing.
What makes Ultraqoz unique is its integration with a telehealth platform. Diagnostic results, including cell counts and images, are automatically uploaded to a secure digital system linked to the patient’s medical ID. Oncologists can then remotely review the results and guide local health workers, making high quality cancer care possible even in remote settings.
Ultraqoz is affordable, easy to use, and designed for resource limited environments, making it a transformative tool for improving cancer outcomes in underserved communities.
Who does your solution serve, and in what ways will the solution impact their lives?
Ultraqoz serves cancer patients in Uganda, particularly those in rural and underserved communities who face critical barriers to diagnosis and treatment monitoring. Our target population includes women with breast cancer, children with leukemia, and patients undergoing chemotherapy at overstretched facilities like the Uganda Cancer Institute.
Currently, these patients are underserved due to long travel distances, high costs, limited access to specialists, and lack of real time monitoring. Many receive chemotherapy without regular follow-up, increasing the risk of treatment failure, complication, or death. Rural clinics often lack the infrastructure for cancer diagnostics, resulting in late-stage detection and high dropout rates from treatment programs.
Ultraqoz addresses these needs by providing a portable, affordable device that enables local health workers to monitor cancer progression through a simple blood test. Diagnostic data is instantly shared via a telehealth platform with oncology specialists, ensuring timely expert review without the need for patient travel.
By decentralizing cancer care, Ultraqoz improves early detection, treatment accuracy, and patient retention. This empowers local providers, reduces costs for families, and improves survival outcomes for thousands of patients who would otherwise fall through the cracks of the healthcare system.
